Bioniz Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL (NCT03239392) | Bioniz Therapeutics | 2018-04-01 |
| A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects (NCT03239379) | Bioniz Therapeutics | 2017-10-30 |
| A First-in-Human Study of BNZ132-1-40 (NCT03046459) | Bioniz Therapeutics | 2016-11-01 |
Track Bioniz Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.